Quarterly report · Q2
7363.TEDINET S100P12N
Period2022-01-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥507m | 2022-01-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥1.0bn | 2021-01-01 → 2021-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥484m | 2021-01-01 → 2021-06-30 | Standalone | Net sales |
| Operating income | −¥3m | 2022-01-01 → 2022-06-30 | Standalone | Operating income |
| Operating income | ¥51m | 2021-01-01 → 2021-06-30 | Standalone | Operating income |
| Ordinary income | −¥4m | 2022-01-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥40m | 2021-01-01 → 2021-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥4m | 2022-01-01 → 2022-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥40m | 2021-01-01 → 2021-06-30 | Standalone | Income before income taxes |
| Net income | −¥5m | 2022-01-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥24m | 2021-01-01 → 2021-06-30 | Standalone | Profit loss |
| Total assets | ¥1.2bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥1.4bn | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥962m | at 2021-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥369m | at 2022-06-30 | Standalone | Liabilities |
| Total liabilities | ¥486m | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥864m | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥872m | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥812m | at 2021-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥883m | at 2022-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2021-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥883m | at 2022-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2021-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥689m | at 2021-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥237m | at 2020-12-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥100m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥96m | 2021-01-01 → 2021-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥37m | 2021-01-01 → 2021-06-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥1m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥17m | 2021-01-01 → 2021-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7m | 2021-01-01 → 2021-06-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | −¥59m | 2022-01-01 → 2022-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥726m | 2021-01-01 → 2021-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥422m | 2021-01-01 → 2021-06-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.61 | 2022-01-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-9.94 | 2022-04-01 → 2022-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.66 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.98 | 2021-01-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.27 | 2021-04-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥78.91 | 2021-01-01 → 2021-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.14 | 2021-01-01 → 2021-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| Equity ratio | 70.1% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.2% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.4% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 941,700 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 912,200 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 897,200 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 15
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥119m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥119m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥388m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥388m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-06-30 | ¥507m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-06-30 | ¥507m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥153m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥153m |
| jpcrp040300-q2r_E36431-000Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥15m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥331m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥331m |
| jpcrp040300-q2r_E36431-000Media Business For Pregnancy Childbirth And Childcarereportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥123m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-01-01 → 2021-06-30 | ¥484m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-01-01 → 2021-06-30 | ¥484m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-01-01 → 2021-06-30 | ¥138m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 386
| Item | Context | Value | Unit |
|---|---|---|---|
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2022-01-01 | |
| Current period end date | FilingDateInstant | 2022-06-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2022-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-01-01 | |
| Comparative period end date | FilingDateInstant | 2021-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2021-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロース | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であり、単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)安田啓司 | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)東京都稲城市 | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)山田育代 | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)静岡県熱海市 | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)株式会社SBI証券 | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)東京都港区六本木一丁目６番１号 | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)福島智晴 | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都西東京市 | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)森帆久 | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)東京都中央区 | |
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)オオサキメディカル株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)愛知県名古屋市西区玉池町203 | |
| Name major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)島田修 | |
| Address major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)東京都八王子市 | |
| Name major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)大崎将男 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |